A. Guzman, “Topical Cantharidin Revisited: A Phase 2 Study Investigating a Commercially-Viable Formulation of Cantharidin (VP-102) for the Treatment of Molluscum Contagiosum”, J of Skin, vol. 2, pp. S103-S104, Dec. 2018.